Participants receiving the 12 mg dose of Retatrutide experienced a weight loss of up to 16.94%, corresponding to approximately 17.5 kg, while the placebo group showed a reduction of only 3.29%
Many patients who did not receive a novel diabetes medication during their hospitalization were at increased risk of cardiovascular, renal or heart failure events and thus most likely to benefit from these medications
USE of glucagon-like peptide 1 receptor agonists (GLP-1RA) is associated with an increased risk of aspiration pneumonia in patients undergoing gastrointestinal endoscopy, according to recent research
Hyperglycemia (high blood sugar) may occur if you do not take enough or skip a dose of your antidiabetic medicine, overeat or do not follow your meal plan, have a fever or infection, or do not exercise as much as usual
Peptides 25 , 18391847 (2004)
Fatigue from Semaglutide is a common early side effect